t/ The purpose of this study was to compare the behavioral, hematological, and biochemical effects of profound arterial hypotension induced by adenosine potentiated with dipyridamole with those of hypotension induced by trimethaphan camsylate or sodium nitroprusside. Twenty dogs were anesthetized with halothane and nitrous oxide, paralyzed with pancuronium, and ventilated to an arterial pCO2 of 40 tort. Arterial pressure and heart rate were monitored continuously. The animals were divided into four groups of five dogs each. The first group served as controls, while in the remaining groups the mean arterial pressure (MAP) was lowered to 40 mm Hg with adenosine/dipyridamole, trimethaphan, or nitroprusside for l hour, following which the animals were allowed to recover from the anesthetic and observed for 48 hours. Determinations of arterial blood gases and hematological and biochemical parameters were made immediately prior to and at the completion of the l-hour hypotensive period and 48 hours later.
sodium nitroprusside p ARENTERALLY administered adenosine is a potent dilator in most vascular beds. 3,1~ In a previous study in dogs, av hypotension to a mean arterial pressure (MAP) of 40 mm Hg could be readily induced, maintained for prolonged intervals without tachyphylaxis, and reversed using adenosine potentiated by dipyridamole. There was no rebound hypertension or cardiovascular toxicity after infusion of adenosine/dipyridamole, and the changes in the cerebral and systemic circulatory parameters were favorable compared to other commonly used hypotensive drugs. 17 Accordingly, it was suggested that adenosine/dipyridamole may be a clinically useful substance for inducing systemic arterial hypotension in neurosurgical patients.
The purpose of this study was to compare the neurological, hematological, and biochemical effects of hypotension induced with sodium nitroprusside, trimethaphan camsylate, and adenosine/dipyridamole in anesthetized dogs. 
Materials and Methods
Twenty mongrel dogs, weighing approximately 15 kg each, were used for this study, The animals were anesthetized with 0.5% halothane and 70% nitrous oxide with 30% oxygen. Muscular paralysis was achieved with pancuronium, 0.15 mg/kg, and the animals were hyperventilated with a pump respirator. Carbon dioxide was added to the inspired gas mixture to maintain arterial pCO2 at 40 torr.
End-tidal CO2 was monitored with an infrared gas analyzer. A femoral artery and vein were catheterized percutaneously for measurement of systemic arterial pressure, for obtaining blood samples, and for infusion of drugs. Four series of experiments were performed, with five dogs in each group. The groups were as follows: control group, adenosine/dipyridamole group, trimethaphan group, and nitroprusside group.
With the exception of the animals in the control group, MAP was lowered to approximately 40 mm Hg for 1 hour by infusing either sodium nitroprusside, trimethaphan camsylate, or adenosine/dipyridamole, after which the hypotensive agents were discontinued. Dipyridamole, 1 mg/kg loading dose supplemented with 0.5 mg/kg intravenously every 30 minutes, was used to potentiate the effect of the adenosine? 7 The animals were then allowed to recover for 45 minutes, at which time the anesthetic was discontinued and the animals allowed to awaken before being returned to their cages for 48 hours of observation. Blood samples were taken for determination of biochemical and hematological parameters in the baseline anesthetized state, at the end of the 1-hour hypotensive period, and at the end of the 48-hour observation period. Table 1 summarizes the changes in heart rate and MAP in the four animal groups. N. F. Kassell, et al. Control Group. In the control animals, there was no significant change in heart rate during the 90-minute observation period. During the time of mock hypotension, arterial pressure had increased approximately 12%.
Results

Heart Rate and Systemic Arterial Pressure
Adenosine/Dipyridamole Group. Hypotension to an MAP of 40 mm Hg (58% reduction) was readily induced with adenosine/dipyridamole. The amount of adenosine required varied between 0.2 and 4.4 mg/ kg/hr. There was no tachyphylaxis during infusion of the agent, and 30 minutes after discontinuation arterial pressure had returned to 79% of control, and thereafter increased without rebound. Heart rate decreased 36% during the hypotensive period and, 30 minutes after the adenosine infusion was stopped, returned to 89% of control values.
Trimethaphan Group. Hypotension was difficult to control with trimethaphan camsylate. An average decrease in MAP to 37 mm Hg (69% reduction) was ultimately achieved, but there was enormous variability in the dose required for the 1-hour hypotensive period, with the totals ranging from 0.2 to 33 mg/kg. In all instances, there was a very slow recovery of arterial pressure following discontinuation of trimethaphan, and 30 minutes after the hypotensive period the pressure had returned to only 50% of baseline. Infusion of trimethaphan camsylate resulted in a 24% reduction in heart rate which recovered to 88% of control 30 minutes after the drug was stopped.
Nitroprusside Group. In the animals in which sodium nitroprusside was used to induce hypotension, MAP could be lowered to 58 mm Hg (41% reduction) only after a toxic amount of the agent (approximately TABLE 3 Changes in serum electrolytes (mEq /liter) * 15 mg/kg) had been administered. After discontinuation of the infusion, arterial pressure did not increase but rather continued to decline progressively, and all animals died shortly thereafter. Heart rate was stable during the hypotensive period but decreased steadily after the nitroprusside was discontinued, declining to 54% of control 30 minutes later.
Neurological Status
The animals in the control group rapidly recovered from the anesthetic and were neurologically intact for the duration of the 48-hour observation period. Likewise, the animals that received adenosine/dipyridamole awakened promptly and behaved normally. The animals in the trimethaphan group were slow to recover from anesthesia, but within 12 hours were neurologically intact and remained so until sacrifice. All of the animals that received nitroprusside died within 3 hours of the hypotensive period.
Arterial Blood Gases
In the control group, there was no significant change in arterial pH, pCO2, or pOe during the 1-hour period of mock hypotension (Table 2 ). In the adenosine/dipyridamole and trimethaphan groups, arterial pCO2 and pO2 did not change statistically, but a metabolic acidosis developed by the end of the 1-hour hypotension period. In the adenosine/dipyridamole group, pH decreased from 7.37 _+ 0.01 to 7.32 + 0.01, and HCO3-decreased from 23 -!-_ 1 to 21 +_ 1 mEq/ liter. In the trimethaphan group, pH decreased from 7.37 _+ 0.01 to 7.31 +_ 0.03, and HCO3-decreased from 23 
Serum Electrolytes
There were few significant changes in serum Na +, K § or C1-observed over the course of the study in the control, adenosine/dipyridamole, trimethaphan, or nitroprusside groups (Table 3) . However, C1-was slightly decreased at 48 hours in the trimethaphan group, and K § was increased following hypotension in the nitroprusside group.
Hematological Parameters
There were no important changes in prothrombin time, partial thromboplastin time, platelet count, or fibrinogen level in any of the groups (Table 4) . Fibrinogen increased in all groups at 48 hours, but the change was statistically significant only in the trimethaphan group. There was a small decrease in prothrombin time at 48 hours in all groups. White blood count was unchanged at 1 hour, and increased slightly in the three surviving groups at 48 hours (Table 5 ). Hemoglobin and hematocrit tended to increase in all groups. The elevations were statistically significant at 48 hours in dogs surviving hypotension. 
Biochemical Profile
In all except the control group, there was a small but statistically significant increase in creatinine and blood urea nitrogen at the end of the 1-hour hypotensive period (Table 6 ). These returned to normal by 48 hours in the adenosine/dipyridamole and trimethaphan groups. There was an increase in blood glucose in all groups after real or mock hypotension. However, this was particularly marked in the animals that received nitroprusside. At the end of the 1-hour hypotensive period, serum glucose had increased 164% in this group.
There were small increases in albumin and total protein in all groups by 48 hours, while bilirubin remained unaltered from baseline levels in all groups throughout the study (Table 7) . There were no changes in lactate dehydrogenase, aspartate aminotransferase, or alkaline phosphatase in any of the groups at the end of the hypotensive period (Table 8) . However, 48 hours later all groups had an elevation in all three enzymes, most marked in alkaline phosphatase, with the exception that lactate dehydrogenase did not increase in the control group.
Changes in serum levels of calcium were minimal, with only small increases occurring in the control group and at 48 hours in the adenosine/dipyridamole group (Table 9) . Phosphorus, however, was increased in all groups after 1 hour of real or mock hypotension, and was decreased from baseline at 48 hours. Cholesterol was unchanged in all groups at 1 hour, but showed a slight increase in all groups at 48 hours. Uric acid levels were unchanged throughout the study, except in the nitroprusside group which showed a fivefold increase at 1 hour.
Discussion
Profound arterial hypotension is now commonly employed in a variety of neurosurgicat procedures.l.6,9,'l,26,28,3~ All of the currently used hypotensive agents, including halothane, nitroprusside, nitroglycerin, and trimethaphan camsylate, have serious drawbacks. These include cyanide toxicity, resistance, tachyphylaxis, rebound hypertension, excessive cerebral vasodilation, and difficulty in controlling the level of hypotension. 4, [6] [7] [8] 18, 22, 24, 26, 32, 35 In a previous study] 7 we demonstrated that adenosine-induced hypotension in the dog compared favorably to these agents in its cerebral and systemic circulatory effects. Adenosine/ * LDH = lactate dehydrogenase; AST = aspartate aminotransferase; Alk P = alkaline phosphatase. Values are means _ standard error of the means. Significance: t = P -< 0.05; ~ = p _< 0.01. dipyridamole hypotension was easily regulated, rapidly reversible, and was not associated with tachyphylaxis or rebound hypertension. 17 A reduction in MAP to 40 mm Hg was chosen in this study because it approximates the level that is frequently used intraoperatively in man. 1~, 16, 23, 25, 28 However, the dog, even under anesthesia, is a difficult animal in which to pharmacologically induce this degree of hypotension# ~ As noted by Michenfelder and Theye 2~ and by us (unpublished data), it was virtually impossible to achieve this level of hypotension using sodium nitroprusside alone without resorting to supratoxic doses, and the reduction in arterial pressure that was ultimately produced proved irreversible. This was probably in large part a manifestation of cardiovascular toxicity, and resulted in the death of all of the animals. Cyanide levels were not measured, but we presume that cyanide poisoning was the cause of death in these animals, as evidenced by the profound metabolic acidoses which developed.
With the ganglionic blocking agent, trimethaphan camsylate, the desired level of hypotension could be achieved. However, it was extremely difficult to regulate the administration of this agent, and hypotension persisted for prolonged intervals after the trimethaphan infusions were discontinued. While the animals in the trimethaphan group were somewhat slow to recover from anesthesia after the hypotensive period, they apparently suffered no lasting effects, as all were neurologically intact within 12 hours.
In contrast to the animals that received sodium nitroprusside or trimethaphan camsylate, hypotension was much more easily controlled with adenosine/ dipyridamole. With these agents, hypotension was readily induced and maintained without tachyphy- laxis. After discontinuation of adenosine administration, arterial pressure promptly returned toward normal levels without overshooting control values. The adenosine infusion resulted in a mild bradycardia which resolved when the drug was discontinued. Adenosine has a direct inhibitory effect on the conduction system of the heart# There was no discernible difference in recovery time or neurological condition between the animals in the control and adenosine groups.
Dipyridamole was used to enhance the effectiveness of adenosine. In a previous study, 17 we demonstrated that the dose of adenosine required to lower arterial pressure to 40 mm Hg in anesthetized dogs could be reduced approximately two orders of magnitude by simultaneously administering dipyridamole. 17 Adenosine administered intravascularly has a very short half-life (approximately 15 seconds). Dipyridamole probably increases the circulating level of adenosine by inhibiting its membrane-bound transport and retarding its inactivation. 1~ As noted previously, the canine model is unusually refractory to pharmacological agents used to produce profound reductions in arterial pressure. Adenosine is relatively insoluble in water at room temperature (0.4 to 0.5 gm/100 ml). Without dipyridamole, the fluid load required to lower the dogs' MAP to 40 mm Hg is approximately 100 ml/kg/hr. We speculate that adenosine alone can effectively be used to produce these levels of hypotension in primates without the burden of excessive fluid administration.
Hypotension induced with trimethaphan camsylate or adenosine/dipyridamole resulted in an equivalent mild metabolic acidosis. However, there was a severe metabolic acidosis caused by the administration of sodium nitroprusside. The cause of the metabolic acidosis in the trimethaphan and adenosine/dipyridamole groups was probably related to hypoperfusion of certain tissues with accumulation of acid metabolites. It has previously been shown that restoration of arterial pressure to normal following 90 minutes of adenosine/dipyridamole-induced hypotension to an MAP of 40 mm Hg results in a reversal of this metabolic acidosis. 17 The severe metabolic acidosis observed in the nitroprusside group was likely related to cyanide toxicity. Arterial pCOz continued to fall as these animals became progressively acidotic, despite the fact that adjustments were made in the inspired CO2 in an attempt to compensate for this, suggesting that CO2 production was reduced in the failing tissues.
There were no important changes in serum electrolytes in any of the groups, with the exception that there was a small but statistically significant increase in potassium in the animals that received sodium nitroprusside. This was presumed to be secondary to the severe metabolic acidosis which had developed.
The mild leukocytosis which was noted in the trimethaphan and adenosine/dipyridamole groups was not specifically related to these agents or the hypotension since it also occurred in the control group. This increase in white blood cell count was probably a response to the stress of anesthesia, as was the increase in fibrinogen. We have no explanation for the increase in hematocrit and hemoglobin observed in all four groups at the end of 1 hour, except for the dog's known ability to release red blood cells from the spleen during stress. The further increase which developed in the surviving animals during the ensuing 24 hours may have been secondary to a failure to drink, resulting in some degree of dehydration and hemoconcentration, although this is purely speculative.
The transient increases in creatinine and blood urea nitrogen which occurred to the same degree in all but the control group can be explained by the decreased renal flow that occurs with hypotension induced by trimethaphan, nitroprusside, and adenosine/dipyridamole. 13,21,27,3~ The elevation in blood glucose which was noted in all four groups was also probably a nonspecific response to stress. The magnitude of the increase was similar in the control, trimethaphan, and adenosine/dipyridamole groups but much greater in the nitroprusside group.
All the animals that survived 48 hours had small increases in total protein and albumin, again of a nonspecific nature. Likewise, the elevation in lactate dehydrogenase, aspartate aminotransferase, and alkaline phosphatase observed at that time were nonspecific for any hypotensive agent, and possibly related to the halothane anesthetic. 12 N. F. Kassell, et al.
These observations suggest that profound arterial hypotension induced with adenosine/dipyridamole for 1 hour in the halothane-anesthetized dog is not accompanied by any adverse physiological, behavioral, hematological, or biochemical changes within 48 hours of administration of the agent. With the exception of a small transient increase in blood urea nitrogen and creatinine, no difference could be detected between the adenosine and control groups. In all respects, the adenosine/dipyridamole group was vastly superior to the nitroprusside group. The ease of regulation and rapid reversibility of adenosine/dipyridamole provided significant advantages over trimethaphan.
Adenosine is a purine found ubiquitously in all mammalian body tissues. It is an inexpensive compound to synthesize. The intravascular half-life of exogenously administered adenosine is 15 seconds; it is rapidly phosphorylated or deaminatedP Adenosine dilates most vascular beds, but it is a mild renal vasoconstrictor. Administered parenterally in sufficient doses, it readily produces profound reductions in arterial pressure. Continuous infusion results in a sustained decrease in pressure without tachyphylaxis. Hypotension rapidly reverses after discontinuation of the infusion, without resulting in rebound hypertension. Adenosine does not cross the blood-brain barrier in significant amounts. Intravenous administration, therefore, does not cause primary cerebral vasodilation and does not interfere with autoregulation. Adenosine used in this manner does not appear to cause any cardiovascular, hematological, central nervous, renal, or hepatic toxicity. These properties suggest that adenosine may be a valuable agent for lowering arterial pressure in a variety of clinical situations.
